Crossmark

H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy

Crossref DOI link: https://doi.org/10.1136/jitc-2022-005693

Published Online: 2023-08-08

Published Print: 2023-08

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Xiao, Chu https://orcid.org/0000-0002-2985-3440
Fan, Tao

Zheng, Yujia

Tian, He

Deng, Ziqin

Liu, Jingjing

Li, Chunxiang

He, Jie https://orcid.org/0000-0003-0327-8852
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81972196)

National Key R&D Program of China (2021YFF1201300, 2020AAA0109505, YS2021YFF120009)

CAMS Innovation Fund for Medical Sciences (2021-1-I2M-012)
License Information

License valid from 2023-08-08